Oncology & Cancer

Patient-reported outcomes predict aromatase inhibitor adherence

If you want to predict which breast cancer patients will most likely stop taking aromatase inhibitors, check out their own responses to the health questions patients commonly answer in cancer clinical trials, according to ...

page 1 from 12